T. Hammett

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

J Carl Barrett, Tracey Hammett, J. Barrett, 2015, Lung cancer.

Clinical Relevance of Dissolution Testing in Quality by Design

Paul A. Dickinson, Bertil Abrahamsson, Wang Wang Lee, 2008, The AAPS Journal.

513O A phase I/II multicenter, first-in-human study of DS-7300 (B7-H3 DXd-ADC) in patients (pts) with advanced solid tumors

Toshio Shimizu, Melissa L. Johnson, M. R. Patel, 2021, Annals of Oncology.

The effect of the CYP3A4 inhibitor, itraconazole, on the pharmacokinetics of ZD6474 in healthy subjects

P. Ghahramani, S. Oliver, T. Hammett, 2005 .

GFR mutation detection in ctDNA from NSCLC patient plasma : A ross-platform comparison of leading technologies to support the linical development of AZD 9291 enneth

T. Hammett, J. Barretta, S. Thressa, 2015 .

Highly Selective Allosteric Modulator of the Phosphoinositide 3‐Kinase Delta (PI3Kδ) Roginolisib In Patients With Refractory/Relapsed Follicular Lymphoma

C. Tarantelli, F. Bertoni, T. Hammett, 2023, Hematological Oncology.